New migraine prevention drug under real-world watch in korea
NCT ID NCT06603558
First seen Jan 24, 2026 · Last updated May 10, 2026 · Updated 12 times
Summary
This study is checking the safety and effectiveness of atogepant, a drug already approved for migraine prevention, in Korean adults. About 3000 people with chronic or episodic migraines will take the drug as prescribed by their doctor and be followed for up to 12 weeks. The goal is to see how well it works and what side effects occur in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hallym University Dongtan Sacred Heart Hospital /ID# 273581
RECRUITINGHwaseong, Gyeonggido, 18450, South Korea
-
Kangbuk Samsung Hospital /ID# 271893
RECRUITINGSeoul, Seoul Teugbyeolsi, 03181, South Korea
-
Seoul National University Hospital /ID# 271892
RECRUITINGSeoul, Seoul Teugbyeolsi, 03080, South Korea
-
Yonsei University Health System Severance Hospital /ID# 272639
RECRUITINGSeoul, Seoul Teugbyeolsi, 03722, South Korea
Conditions
Explore the condition pages connected to this study.